This article is a correction to:
Cardioprotective effect of Sanguisorba minor against isoprenaline-induced myocardial infarction in rats
Azar Hosseini1,2Atieh Ghorbani3Mohaddeseh Sadat Alavi2Nima Forouhi1Arezoo Rajabian4Samaneh Boroumand-Noughabi5
Amirhossein Sahebkar6,7*
Ali H. Eid8*- 1Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- 2Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran
- 3Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- 4Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran
- 5Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- 6Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
- 7Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
- 8Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar
A Corrigendum on
Cardioprotective effect of Sanguisorba minor against isoprenaline-induced myocardial infarction in rats
by Hosseini A, Ghorbani A, Alavi MS, Forouhi N, Rajabian A, Boroumand-Noughabi S, Sahebkar A and Eid AH (2023). Front. Pharmacol. 14:1305816. doi: 10.3389/fphar.2023.1305816
In the published article, there was an error in Figure 4A as published. During the last stage of revision, labels in Figure 4A were inadvertently altered, and the group labels in the figure were mistakenly substituted. The corrected Figure 4A appears below:
FIGURE 4
FIGURE 4. Effect of S. minor on the levels of cTn-T, CK-MB, LDH, and CPK after isoproterenol administration. The levels of cTn-T (A), CK-MB (C), CPK (B), and LDH (D) were evaluated in serum. Data were expressed as mean ± SEM. ###p < 0.001 in comparison with the control group. ***p < 0.001 in comparison with isoprenaline (85 mg/kg).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: myocardial infarction, isoprenaline, oxidative stress, cardiotoxicity, herbal medicine, superoxide dismutase
Citation: Hosseini A, Ghorbani A, Sadat Alavi M, Forouhi N, Rajabian A, Boroumand-Noughabi S, Sahebkar A and Eid AH (2024) Corrigendum: Cardioprotective effect of Sanguisorba minor against isoprenaline-induced myocardial infarction in rats. Front. Pharmacol. 15:1374595. doi: 10.3389/fphar.2024.1374595
Received: 22 January 2024; Accepted: 12 February 2024;
Published: 21 February 2024.
Edited and reviewed by:
Syed Shams Ul Hassan, Shanghai Jiao Tong University, ChinaCopyright © 2024 Hosseini, Ghorbani, Sadat Alavi, Forouhi, Rajabian, Boroumand-Noughabi, Sahebkar and Eid. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Amirhossein Sahebkar, amir_saheb2000@yahoo.com; Ali H. Eid, ali.eid@qu.edu.qa